Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2670658, 8 pages
https://doi.org/10.1155/2017/2670658
Research Article

miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway

1Department of Liver Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
2Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China
3Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China
4Department of Biliary and Pancreatic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
5School of Life Sciences, Sun Yat-sen University, Guangzhou 510080, China

Correspondence should be addressed to Yunpeng Hua; moc.361@7240pyh and Quentin Liu; nc.ude.usys.liam@9quil

Received 5 February 2017; Accepted 21 March 2017; Published 13 June 2017

Academic Editor: Goutam Ghosh Choudhury

Copyright © 2017 Tengfei Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Hernandez-Gea and S. L. Friedman, “Pathogenesis of liver fibrosis,” Annual Review of Pathology, vol. 6, pp. 425–456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. E. A. Tsochatzis, J. Bosch, and A. K. Burroughs, “Liver cirrhosis,” The Lancet, vol. 383, no. 9930, pp. 1749–1761, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Ramos-Lopez, E. Martinez-Lopez, S. Roman, N. A. Fierro, and A. Panduro, “Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico,” World Journal of Gastroenterology, vol. 21, no. 41, pp. 11552–11566, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Liu, J. Yi, R. Ye et al., “miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver,” International Journal of Clinical and Experimental Pathology, vol. 8, pp. 3994–4000, 2015. View at Google Scholar
  5. N. Ikeda, S. Murata, T. Maruyama et al., “Platelet-derived adenosine 5'-triphosphate suppresses activation of human hepatic stellate cell: In vitro study,” Hepatology Research, vol. 42, no. 1, pp. 91–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Bansal, J. van Baarlen, G. Storm, and J. Prakash, “The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis,” Scientific Reports, vol. 5, Article ID 18272, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Mikula, V. Proell, A. N. M. Fischer, and W. Mikulits, “Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-β dependent fashion,” Journal of Cellular Physiology, vol. 209, no. 2, pp. 560–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Taura, S. de Minicis, E. Seki et al., “Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis,” Gastroenterology, vol. 135, no. 5, pp. 1729–1738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. B.-B. Wang, J.-Y. Cheng, H.-H. Gao, Y. Zhang, Z.-N. Chen, and H. Bian, “Hepatic stellate cells in inflammation-fibrosis-carcinoma axis,” Anatomical Record, vol. 293, no. 9, pp. 1492–1496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Lambrecht, I. Mannaerts, and L. A. van Grunsven, “The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis,” Frontiers in Physiology, vol. 6, article 209, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Du, X. Niu, Y. Wang et al., “MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a,” Scientific Reports, vol. 5, Article ID 16163, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Coll, A. E. Taghdouini, L. Perea et al., “Integrative miRNA and gene expression profiling analysis of human quiescent hepatic stellate cells,” Scientific Reports, vol. 5, Article ID 11549, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Yang, S. Banerjee, A. de Freitas et al., “Participation of miR-200 in pulmonary fibrosis,” The American Journal of Pathology, vol. 180, no. 2, pp. 484–493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Murakami, H. Toyoda, M. Tanaka et al., “The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families,” PLoS ONE, vol. 6, no. 1, Article ID e16081, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Y. Feng, X. Q. Xu, C. B. Ji, C. M. Shi, X. R. Guo, and J. F. Fu, “Aberrant hepatic MicroRNA expression in nonalcoholic fatty liver disease,” Cellular Physiology and Biochemistry, vol. 34, no. 6, pp. 1983–1997, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Xiao, J. Wang, Y. Chen et al., “Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling,” Cellular Signalling, vol. 26, no. 5, pp. 925–932, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Sun, Y. He, T.-T. Ma, C. Huang, L. Zhang, and J. Li, “Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation,” Molecular and Cellular Biochemistry, vol. 388, no. 1-2, pp. 11–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Hua, S. White-Gilbertson, J. Kellner et al., “Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma,” Clinical Cancer Research, vol. 19, no. 22, pp. 6242–6251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Kim, S. Wang, J. Hyun et al., “Hepatic stellate cells express thymosin beta 4 in chronically damaged liver,” PLoS ONE, vol. 10, no. 3, Article ID e0122758, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Reif, A. Lang, J. N. Lindquist et al., “The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression,” Journal of Biological Chemistry, vol. 278, no. 10, pp. 8083–8090, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Hyun, J. H. Lee, H. Jin et al., “Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K,” Cell, vol. 139, no. 6, pp. 1096–1108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. T. Park, M. Kato, H. Yuan et al., “FOG2 protein down-regulation by transforming growth factor-β1-induced MicroRNA-200b/c leads to akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy,” The Journal of Biological Chemistry, vol. 288, no. 31, pp. 22469–22480, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Mei, J. Xin, Y. Liu et al., “MicroRNA-200c promotes suppressive potential of myeloid-derived suppressor cells by modulating PTEN and FOG2 expression,” PLoS ONE, vol. 10, no. 8, Article ID e0135867, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. G. Bachem, U. Riess, and A. M. Gressner, “Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta,” Biochemical and Biophysical Research Communications, vol. 162, no. 2, pp. 708–714, 1989. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Zhang, J. Zhang, X. Jiang et al., “Heparin-binding epidermal growth factor-like growth factor: a hepatic stellate cell proliferation inducer via ErbB receptors,” Journal of Gastroenterology and Hepatology, vol. 29, no. 3, pp. 623–632, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. B. C. Fuchs, Y. Hoshida, T. Fujii et al., “Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma,” Hepatology, vol. 59, no. 4, pp. 1577–1590, 2014. View at Publisher · View at Google Scholar · View at Scopus